Rohit Adyanthaya, M.D.

Rohit Adyanthaya, M.D.Gulf Coast Eye Institute
1205 Ed Carey Drive
Harlingen, TX 78550
(956) 320-7510

Education and Training

  • Ophthalmology Fellowships -
    • 1. Johns Hopkins University (Wilmer Eye Institute), Baltimore, MD.
    • 2. Valley Retina Institute, McAllen, Texas.
  • Ophthalmology Residency - State University of New York (SUNY), Stony Brook, NY.
  • Internal Medicine Internship - Good Samaritan Hospital, Baltimore, MD.
  • Ophthalmology Residency - King Edward Memorial Hospital, University of Mumbai, India.
  • Doctor of Medicine - University of Mumbai, India.

Certification: American Board of Ophthalmology

Journal Publications:

  • Rohit Adyanthaya. Optimizing laser Treatment for Diabetic Macular Edema. New Retina MD. October 2013.
  • Irsch K, Guyton DL, Ramey NA, Adyanthaya RS, Ying HS. Vertical Vergence Adaptation Produces an Objective Vertical Deviation that Changes with Head Tilt. Invest Ophthalmol Vis Sci. 2013 Apr 9.
  • R.Honkanen, R. Adyanthaya, T. Chou, S.Y.Wu, M.A. Torab Parhiz, M. Kaku, T. Haque, N. Mehta. Evaluation Of 5 Intraocular Lens Power Prediction Formulas In Early Resident Surgical Training. Journal of Academic Ophthalmology.
  • Adyanthaya R, Chou T, Torab Parhiz A. Penetrating ocular trauma from airsoft gun. Arch Ophthalmol 2012;130:944-5.
  • Chou TY, Adyanthaya R. Infectious crystalline keratopathy associated with Klebsiella oxytoca. J Ophthalmic Inflamm Infect. 2012 Mar 25.
  • Akpek EK, Lindsley KB, Adyanthaya R, Swamy R, Baer A, McDonnell P. Treatment of Sjögren’s Syndrome–Associated Dry Eye: An Evidence-Based Review. Ophthalmology. 2011 Jul;118(7):1242-52. Epub 2011 Apr 3.
  • Adyanthaya R, Brumm M, Ibrahim M, Do D, Nguyen Q. Neovascular Age-Related Macular Degeneration: Current Concepts in Management. AAO Focal Points: Clinical Modules for Ophthalmologists: Module 12, 2010.
  • Adyanthaya RS, Folgar FA, Akpek EK. Medical management of acutely recurring pterygium with topical mitomycin-C. J Cataract Refract Surg. 2009 Jan;35(1):200-2.
  • Adyanthaya RS, Ying HS, Handa JT, Repka MX. Macular retinal detachment in Hallermann-Streiff syndrome. Arch Ophthalmol. 2008 Feb;126(2):271-3.
  • C F Parsa and R Adyanthaya. Why atropine drops should be used in Down syndrome. Br J Ophthalmol 2008; 92: 295-296.
  • Rohit S. Adyanthaya, Michael X. Repka. A rare case of WAGR syndrome with Peter anomaly. Eye Reports 2011; 1:e4.
  • R Adyanthaya, R Honkanen. Behind the Masquerade. EyeNet. American Academy of Ophthalmology (AAO) publication. January 2012.
  • Adyanthaya R. Multiple cutaneous metastases from esophageal adenocarcinoma. J Gastrointest Cancer. 2008;39(1-4):22-5.
  • Omar Punjabi, Rohit Adyanthaya, Ashwini Mhatre, RP Jehangir. Rheumatoid arthritis is a risk factor for dry eye in the Indian population. Ophthalmic Epidemiology, 13:1-6, 2006, ISSN: 0928-6586.
  • Rohit Adyanthaya, Anirudha Mahendrakar, S.P.Kerkar. Optic Nerve Avulsion. Ophthalmology Today. May-June 2004, vol-5, no.1, pg.34, ISSN 09723323.
  • Rohit Adyanthaya, Anirudha Mahendrakar, S.P.Kerkar. Preseptal orbital lymphoma. Ophthalmology Today. Nov-Dec 2004. Vol 5, no.4, pg.22, ISSN 09723323.

Presentation at National Conferences:

  • Adyanthaya, R, Gonzalez, V: Evaluation of Retinal Electrophysiology During One Year Treatment of Proliferative Diabetic Retinopathy With Intravitreal Pegaptanib Sodium (Macugen). Annual Meeting of the American Society of Retinal Specialists (ASRS) 2013.
  • Adyanthaya, R, Zavala, G, Gonzalez, V: Subthreshold Micropulse Diode Laser Photocoagulation as Monotherapy for Mild to Moderate Diabetic Macular Edema. Invest. Ophthalmol. Vis. Sci. 2013;54(6):E-Abstract 2381
  • Brinda Muthusamy, Rohit Adyanthaya, Sheena Broome, Kristina Irsch, David L Guyton. Down syndrome and accommodation: The added advantage of bifocals. Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2013.
  • M Tanderup, J Tsai, S Prabhu, R Adyanthaya, B Roobini, P Sibony. Sign out database for inpatient and emergency room consults - Smooth transition for residents and attendings. 2011 Accreditation Council for Graduate Medical Education (ACGME) meeting.
  • R Adyanthaya, Timothy Chou, Lorena LoVerde. Infectious Crystalline Keratopathy Caused by Klebsiella Oxytoca. 2011 American Society of Cataract and Refractive Surgery (ASCRS) meeting.
  • R.Honkanen, R. Adyanthaya, T. Chou, S.Y.Wu, M.A. Torab Parhiz, M. Kaku, T. Haque, N. Mehta. Evaluation Of 5 Intraocular Lens Power Prediction Formulas In Early Resident Surgical Training. Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2010.
  • R Adyanthaya, R Swamy, E Akpek. Treatment of Sjögren’s Syndrome-Associated Dry Eye:An Evidence-Based Review. Annual Meeting of the American Society of Cataract and Refractive Surgery (ASCRS) 2009.
  • Kristina Irsch, Howard S. Ying, Nicholas A. Ramey, Rohit Adyanthaya, David L. Guyton. Head Movement Compensation for Novel Haploscopic Eye Tracking Apparatus. Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2008.
  • H. S. Ying, K. Irsch, R. Vaswani, A. Kurz, N. A. Ramey, R. S. Adyanthaya, D. S. Zee, and D. L. Guyton. Ocular Counter-Roll Is Decreased After Vertical Vergence Adaptation. Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2008.
  • H. S. Ying, K. Irsch, R. Vaswani, A. Kurz, N. A. Ramey, R. S. Adyanthaya, D. S. Zee, and D. L. Guyton. Ocular Counter-Roll Is Decreased After Vertical Vergence Adaptation. XXV Bárány Society Meeting, Kyoto, Japan. 2008.
  • Rohit Adyanthaya. Delayed Onset Endophthalmitis. Annual meeting of American College of Physicians (ACP), Baltimore 2008
  • R.S. Adyanthaya, N. Ramey, M.C. Müllenbroich, K. Irsch, H.S. Ying, D.L. Guyton (2007) A Novel Haploscopic Viewing Apparatus With a Three Axis Eye Tracker. Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2008.
  • Omar Punjabi, Rohit Adyanthaya, Ashwini Mhatre, RP Jehangir. Rheumatoid arthritis is a risk factor for dry eye in the Indian population. Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) 2006.

Selected Talks:

  • Micropulse laser in diabetic macular edema – Presented at the American Academy of Ophthalmology Meeting in New Orleans in November 2013
  • Age Related Macular Degeneration – Seminar in August 2012 at Mcallen, Texas
  • Low Vision Aids and Visual Rehabilitation - Seminar in September 2010 at Stony Brook, New York.
  • Cyclovertical vergence adaptation and Superior oblique palsy- Talk at the Annual Johns Hopkins Hospital (Wilmer Eye Institute) Research Meeting in 2007.

Clinical Trials:

  • Sub-Investigator: DRCRnet - Prompt Panretinal Photocoagulation versus Intravitreal Ranibizumab with Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
  • Sub-Investigator: DRCRnet - Treatment for Central-Involved Diabetic Macular Edema in Eyes with Very Good Visual Acuity
  • Sub-Investigator: An open label dose escalation study of PF-04523655 (Stratum I) combined with a prospective, randomized, double-masked multi-center, controlled study (Stratum II) evaluating the efficacy and safety of PF-04523655 alone and in combination with a ranibizumab versus ranibizumab alone in diabetic macular edema (Matisse study). Protocol: QRK 202.
  • Sub-Investigator: A randomized, Sham-Controlled, double-masked multicenter study evaluating ocriplasmin treatment for symptomatic vitreomacular adhesion including macular hole (OASIS). Protocol TG-MV-014.
  • Sub-Investigator: An open label, multi-center extension study of the safety and utility of the new inserter of ILUVIEN( Fluocinolone Acetonide Intravitreal Insert) 0.19 mg and the safety of ILUVIEN in subjects with Diabetic Macular Edema. Protocol C-01-11-008.
  • Sub-Investigator: An open –label, long –term, safety and tolerability extension study of Intravitreal Trap-Eye in Neovascular Age-related Macular Degeneration. Protocol VGFT-0910.
  • Sub-Investigator: A Phase 2 Multi-Center, Randomized, Double-Masked, Placebo-Controlled, Multi-Dose Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of RN6G (PF-04382923) in Subjects with Geographic Atrophy Secondary to Age-related Macular Degeneration. Protocol: Pfizer.
  • Sub-Investigator: A Phase IIB Multicenter, Randomized, Double-Masked Study of the Safety and Efficacy of Difluprednate 0.05% Ophthalmic Emulsion Compared to Prednisolone Acetate 1.0% Ophthalmic Suspension in the Treatment of Endogenous Anterior Uveitis. Protocol: X052130 Xoma.
  • Sub-Investigator: A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination with Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema with Involvement of the Foveal Center. Protocol: iDEAL

Awards:

  • 2011 American Society of Cataract and Refractive Surgery (ASCRS) Resident Excellence Award
  • Wilmer research grant award for work on ‘Cyclovertical vergence adaptation and Superior oblique palsy'.

Professional Societies:

  • American Board of Ophthalmology
  • American Academy of Ophthalmology
  • American Society of Retina Specialists
  • Association for Research in Vision and Ophthalmology
  • American Society of Cataract and Refractive Surgery
  • International Council of Ophthalmology
  • Texas Medical Association

Dr. Rohit Adyanathaya is a physician on the staff of Valley Retina Institute. P.A.